The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict LHC Group's revenues will grow 2.1% and EPS will decrease -5.1%.
The average estimate for revenue is $160.9 million. On the bottom line, the average EPS estimate is $0.37.
Last quarter, LHC Group reported revenue of $158.9 million. GAAP reported sales were 3.6% higher than the prior-year quarter's $153.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.38. GAAP EPS were $0.36 for Q3 compared to -$2.08 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.6%, 20 basis points worse than the prior-year quarter. Operating margin was 7.7%, 140 basis points better than the prior-year quarter. Net margin was 4.0%, much better than the prior-year quarter.
The full year's average estimate for revenue is $636.7 million. The average EPS estimate is $1.50.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 224 members out of 233 rating the stock outperform, and nine members rating it underperform. Among 62 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 59 give LHC Group a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on LHC Group is outperform, with an average price target of $19.07.
Is LHC Group the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add LHC Group to My Watchlist.